WEBINAR: FDA Diversity Guidance and Unmet Needs in Outcome Measures
View Thalocan CEO Eric Zudak’s presentation to the New York SOCRA Chapter examining the challenges with endpoints as it relates to enrollment diversity in dermatology trials. View Webinar